FY2024 EPS Estimates for Green Thumb Industries Inc. (OTCMKTS:GTBIF) Decreased by Analyst

Green Thumb Industries Inc. (OTCMKTS:GTBIF) – Research analysts at Cormark decreased their FY2024 earnings per share (EPS) estimates for Green Thumb Industries in a research report issued on Monday, November 13th. Cormark analyst J. Pytlak now forecasts that the company will post earnings per share of $0.22 for the year, down from their previous forecast of $0.26. The consensus estimate for Green Thumb Industries’ current full-year earnings is $0.21 per share.

GTBIF has been the topic of several other reports. Stifel Nicolaus reduced their price target on Green Thumb Industries from C$30.00 to C$22.00 in a research note on Monday, July 31st. Alliance Global Partners lowered their price target on shares of Green Thumb Industries from C$21.00 to C$19.00 in a research report on Wednesday, August 9th.

Green Thumb Industries Stock Performance

GTBIF stock opened at $10.29 on Tuesday. Green Thumb Industries has a fifty-two week low of $6.42 and a fifty-two week high of $16.50. The company has a market capitalization of $2.20 billion, a price-to-earnings ratio of -128.63 and a beta of 1.51. The business’s 50 day moving average price is $10.02 and its two-hundred day moving average price is $8.35.

Green Thumb Industries (OTCMKTS:GTBIF) last announced its earnings results on Wednesday, November 8th. The company reported $0.05 earnings per share for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.01). Green Thumb Industries had a negative net margin of 1.76% and a positive return on equity of 2.64%. The company had revenue of $275.40 million for the quarter, compared to the consensus estimate of $257.19 million.

Green Thumb Industries Company Profile

Green Thumb Industries Inc engages in the manufacture, distribution, and sale of various cannabis products for medical and adult-use in the United States. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.